发明名称 Matrixmetalloproteaseinhibitorer
摘要 A compound of the general formula Iwherein Y is O or S;n is 1, 2, 3 or 4;X represents hydroxamic acid, carboxylic acid, phosphonic acid, acetylthiomethyl group or a mercaptomethyl group;R1 iswherein E, when present represents, a bond or optionally substituted methylene or ethylene;s and t are independently 0, 1, 2 or 3;A and A' independently represent a bond, or a saturated or unsaturated, optionally substituted cyclic or heterocyclic hydrocarbon di- or triradical;Z represents a bond, O, S, C(O), C(O)NR7, NR7C(O) or NR7, wherein R7 is hydrogen, hydroxy, branched or straight, saturated or unsaturated, optionally substituted hydrocarbon radical;R5 represents a bond, alkane or alkene diradical, one or more ether diradicals (R-O-R') or amine diradicals (R-N-R'), wherein R and R' independently represent alkane or alkene diradicals with a C-content from 0 to 3;R6 represents hydrogen, hydroxy, halogen, cyano, nitro, branched or straight, saturated or unsaturated, optionally substituted hydrocarbon radical, unsaturated optionally substituted cyclic or heterocyclic hydrocarbon radical, NR8R9, C(O)NR8R9, C(O)R8, CO(O)R8, S(O)2R9, wherein each R8 and R9 independently represent hydrogen, halogen, a branched or straight, saturated or unsaturated, optionally substituted hydrocarbon radical;R2 represents hydrogen, (C1-8)alkyl, (C2-6)alkenyl, (C3-8)cycloalkyl, aryl(C0-6)alkyl or heteroaryl(C0-6)alkyl;provided that if A, A', Z and R5 are all bonds, and s and t are both 0 (zero), then R6 is different from hydrogen;or a salt, hydrate or solvate thereof.The compounds are valuable for human and veterinary therapy.
申请公布号 DK1303527(T3) 申请公布日期 2005.01.31
申请号 DK20010949275T 申请日期 2001.07.03
申请人 LEO PHARMA A/S 发明人 BLAEHR, LARS, KRISTIAN, ALBERT;SORENSEN, MORTEN, DAHL;CHRISTENSEN, METTE, KNAK
分类号 A61K31/675;C07F9/6584;(IPC1-7):C07F9/658 主分类号 A61K31/675
代理机构 代理人
主权项
地址